Gabelli & Co Investment Advisers’s Akcea Therapeutics Inc AKCA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-147,574	Closed	-$2.68M	–	394
2020 Q3	$2.68M	Buy	+147,574	New	+$2.09M	0.48%	47

Gabelli & Co Investment Advisers's AKCA Position: Q4 2020 in Review

Gabelli & Co Investment Advisers sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 147,574 shares — an estimated $2.68M sold.

Gabelli & Co Investment Advisers first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $2.68M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Gabelli & Co Investment Advisers reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 147,574 Akcea Therapeutics Inc shares in Q4 2020, an estimated $2.68M.
Gabelli & Co Investment Advisers first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Akcea Therapeutics Inc position peaked at $2.68M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.